New drug combo aims to shrink Hard-to-Treat tumors

NCT ID NCT07229638

First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 22 times

Summary

This study tests a new drug called SHR-9839 combined with other anti-tumor treatments for people with advanced solid tumors. The goal is to see if the combination is safe and helps shrink or control tumors. About 70 adults aged 18-70 with measurable tumors and good performance status will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fudan University Affiliated Cancer Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial People's Hospital

    RECRUITING

    Nanjing, Jiangsu, 210029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.